This resistance may be mediated by the secretion of hepatocyte growth factor (HGF) by PDPN-positive CAFs, which activates the mesenchymal-epithelial transition (MET) signaling pathway and promotes cancer cell survival and growth. Here, PDPN is linked to cancer.